Coeptis Therapeutics Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Coeptis Therapeutics Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q2 2024.
  • Coeptis Therapeutics Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $79.1K, a 103% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $79.1K +$40.1K +103% Jun 30, 2024 10-Q 2024-08-16
Q1 2024 $88.4K +$39.4K +80.3% Mar 31, 2024 10-Q/A 2024-08-16
Q4 2023 $97.6K +$38.7K +65.6% Dec 31, 2023 10-Q 2024-08-16
Q3 2023 $28.7K Sep 30, 2023 10-Q/A 2024-08-16
Q2 2023 $39K Jun 30, 2023 10-Q/A 2024-03-25
Q1 2023 $49.1K Mar 31, 2023 10-Q/A 2024-03-25
Q4 2022 $58.9K +$41K +229% Dec 31, 2022 10-K/A 2024-08-16
Q4 2021 $17.9K Dec 31, 2021 10-K/A 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.